With 2006 revenue of more than $1.7 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of clinical laboratories, delivering innovative solutions to customers and enhancing the quality of life for patients.

The businesses from which Dade Behring was formed have been innovators in clinical diagnostics for more than a century. Dade Behring was created in 1997 through the merger of Dade International and the Behring Diagnostics unit of Hoechst AG. Earlier, these companies had combined the diagnostics businesses of the DuPont Company, Syva Company and Baxter Healthcare. Now, Dade Behring ranks as the sixth largest diagnostics company in the world.

The company has four core product lines: Chemistry/Immunochemistry, Hemostasis, Microbiology and Infectious Disease Diagnostics.

Dade Behring's Core Chemistry business consists of: Routine Chemistry/Immunochemistry, Cardiac, Plasma Proteins and Drugs-of-Abuse Testing/Therapeutic Drug Monitoring. These products are used to detect and measure substances that may be found in patients' blood, urine or tissue samples. Key products include the following:

Routine chemistry/ immunochemistry testing: The Dimension® family of products remain the only systems in the marketplace that integrate highly sensitive immunochemistry testing into the same instrument as routine chemistry testing. This unique product capability can eliminate the need for multiple instruments, simplifying workflow, reducing overall costs, and increasing efficiency in the clinical laboratory. Dade Behring also offers workcells that automate labor-intensive activities by connecting up to six Dimension® analyzers.

Cardiac testing: In addition to its broad cardiac test menu on the Dimension® systems, Dade Behring also offers a highly advanced, automated bench-top analyzer called the Stratus® CS Acute Care Diagnostic System. The company is an industry leader in introducing highly-sensitive cardiac marker tests, including Troponin I, high-sensitivity c-reactive protein (hsCRP), and the NT-proBNP tests.

Plasma Protein testing: Dade Behring's plasma protein tests diagnose a range of disease and disorders, from heart disease, rheumatic disease, tumors, malnutrition and more through the testing of serum, plasma, urine or cerebral/spinal fluid.

Drugs-of-abuse testing (DAT) and therapeutic drug monitoring (TDM): Drugs-of-abuse tests screen for the presence of illicit drugs in a patient's system, while monitoring of therapeutic drugs enable physicians to ensure that therapeutic drugs are present in safe levels in the bloodstream. The Syva® brand remains, after three decades, the leading brand in the drugs-of-abuse and therapeutic drug monitoring market.

Dade Behring was a pioneer in the field of Hemostasis (coagulation), and it continues to maintain a global leadership position in this product line. Many of its hemostasis tests measure patients' ability to form and dissolve blood clots, and are generally used before and during surgical procedures or for monitoring coagulation disorders such as hemophilia.

Microbiology laboratories use Dade Behring's highly specific MicroScan® products to identify infection-causing bacteria and the minimum dose of antibiotics necessary to treat the infection - critical data in managing patient therapy and health care resources. Dade Behring has taken a leadership role in detecting emerging antimicrobial resistance, and is the only company offering an automated system cleared for improved detection of vancomycin-resistant Staphylococcus aureus (VRSA).

Outside of the U.S. market, Dade Behring's Infectious Disease Diagnostics (IDD) systems are primarily used for virology testing, including screening for infections such as hepatitis, HIV and sexually transmitted diseases.

Dade Behring is headquartered in Deerfield, Illinois, and has operations in 35 countries, employs approximately 6,400 people and serves more than 25,000 customers worldwide.

MISSION

Enhance people's lives by being the most responsive provider of quality diagnostic products and services to our customers, thereby building value for all our stakeholders.

VISION

To be the leading global diagnostic company.

VALUES

Respect:
Our key asset is our people. We treat others with respect, create opportunity for growth and development, recognize personal considerations and encourage mentoring.

Teamwork:
We maximize effectiveness and learning through teamwork. Personal interests must not come before team goals.

Integrity:
We highly value our reputation for integrity, honesty, fair dealing and ethical conduct. We will not compromise ethical standards or personal integrity.

Customer Focus:
We are highly responsive and focused on our customers and their needs.

Bias for Action and Quality Results:
We have a bias for action and quality results. We embrace change, challenge the status quo, and take the initiative to identify and implement improvements in processes, systems, and work environments.